James E. Haddow

16.0k total citations · 5 hit papers
183 papers, 11.2k citations indexed

About

James E. Haddow is a scholar working on Pediatrics, Perinatology and Child Health, Obstetrics and Gynecology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, James E. Haddow has authored 183 papers receiving a total of 11.2k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Pediatrics, Perinatology and Child Health, 35 papers in Obstetrics and Gynecology and 27 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in James E. Haddow's work include Prenatal Screening and Diagnostics (69 papers), Pregnancy and preeclampsia studies (32 papers) and Parvovirus B19 Infection Studies (24 papers). James E. Haddow is often cited by papers focused on Prenatal Screening and Diagnostics (69 papers), Pregnancy and preeclampsia studies (32 papers) and Parvovirus B19 Infection Studies (24 papers). James E. Haddow collaborates with scholars based in United States, United Kingdom and Ireland. James E. Haddow's co-authors include Glenn E. Palomaki, George J. Knight, Jacob A. Canick, Louis M. Neveux, Josephine Williams, Edward M. Kloza, Walter C. Allan, Robert Z. Klein, James D. Faix and Geralyn Lambert‐Messerlian and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

James E. Haddow

180 papers receiving 10.5k citations

Hit Papers

Maternal Thyroid Deficiency during Pregnancy and Subseque... 1988 2026 2000 2013 1999 1988 2011 2009 2012 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Maternal Thyroid Deficiency during Pregnancy and Subsequent Neuropsychological Development of the Child
    1999 1.7k citations James E. Haddow, Glenn E. Palomaki et al. New England Journal of Medicine profile →
  2. Maternal serum screening for Down's syndrome in early pregnancy.
    1988 709 citations N J Wald, Howard Cuckle et al. BMJ profile →
  3. DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study
    2011 660 citations Glenn E. Palomaki, Edward M. Kloza et al. Genetics in Medicine profile →
  4. The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group
    2009 484 citations Linda Bradley, Glenn E. Palomaki et al. Genetics in Medicine profile →
  5. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study
    2012 392 citations Glenn E. Palomaki, Cosmin Deciu et al. Genetics in Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James E. Haddow United States 48 5.6k 2.9k 1.7k 1.6k 1.4k 183 11.2k
Glenn E. Palomaki United States 52 6.3k 1.1× 2.8k 1.0× 2.0k 1.1× 1.8k 1.1× 1.7k 1.2× 255 14.2k
George J. Knight United States 33 3.5k 0.6× 1.4k 0.5× 1.1k 0.6× 935 0.6× 676 0.5× 90 6.1k
Allan Hackshaw United Kingdom 50 3.4k 0.6× 379 0.1× 1.7k 1.0× 656 0.4× 1.9k 1.4× 202 10.7k
Samuel Shapiro United States 58 1.7k 0.3× 864 0.3× 215 0.1× 851 0.5× 1.3k 1.0× 184 10.9k
Charles J. Glueck United States 74 2.0k 0.4× 6.6k 2.3× 289 0.2× 1.6k 1.0× 5.8k 4.2× 536 20.7k
David W. Kaufman United States 57 1.1k 0.2× 812 0.3× 345 0.2× 448 0.3× 1.5k 1.1× 178 11.1k
Jan Lindemans Netherlands 55 2.1k 0.4× 455 0.2× 278 0.2× 1.1k 0.7× 1.4k 1.0× 217 9.9k
Claudia Langenberg United Kingdom 54 972 0.2× 1.9k 0.7× 495 0.3× 358 0.2× 1.6k 1.2× 144 11.8k
Norberto Perico Italy 65 1.4k 0.3× 1.1k 0.4× 328 0.2× 392 0.3× 3.7k 2.7× 292 14.2k
Ronald C.W. Hong Kong 66 1.9k 0.3× 5.9k 2.1× 176 0.1× 2.4k 1.5× 2.7k 2.0× 493 15.6k

Countries citing papers authored by James E. Haddow

Since Specialization
Citations

This map shows the geographic impact of James E. Haddow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James E. Haddow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James E. Haddow more than expected).

Fields of papers citing papers by James E. Haddow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James E. Haddow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James E. Haddow. The network helps show where James E. Haddow may publish in the future.

Co-authorship network of co-authors of James E. Haddow

This figure shows the co-authorship network connecting the top 25 collaborators of James E. Haddow. A scholar is included among the top collaborators of James E. Haddow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James E. Haddow. James E. Haddow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haddow, James E., Wendy Y. Craig, Louis M. Neveux, et al.. (2014). Implications of High Free Thyroxine (FT4) Concentrations in Euthyroid Pregnancies: The FaSTER Trial. The Journal of Clinical Endocrinology & Metabolism. 99(6). 2038–2044. 33 indexed citations
2.
Haddow, James E., Monica R. McClain, Glenn E. Palomaki, et al.. (2011). Thyroperoxidase and Thyroglobulin Antibodies in Early Pregnancy and Placental Abruption. Obstetrics and Gynecology. 117(2). 287–292. 18 indexed citations
3.
Palomaki, Glenn E., Edward M. Kloza, Geralyn Lambert‐Messerlian, et al.. (2011). DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study. Genetics in Medicine. 13(11). 913–920. 660 indexed citations breakdown →
4.
Haddow, James E., Jane Cleary‐Goldman, Monica R. McClain, et al.. (2010). Thyroperoxidase and Thyroglobulin Antibodies in Early Pregnancy and Preterm Delivery. Obstetrics and Gynecology. 116(1). 58–62. 51 indexed citations
5.
Craig, Wendy Y., Marie Roberson, Glenn E. Palomaki, et al.. (2010). Prevalence of steroid sulfatase deficiency in California according to race and ethnicity. Prenatal Diagnosis. 30(9). 893–898. 35 indexed citations
6.
Bradley, Linda, et al.. (2007). A Genetic History Questionnaire-Based System in Primary Prenatal Care to Screen for Selected Fetal Disorders. Genetic Testing. 11(3). 291–295. 2 indexed citations
7.
Bdolah, Yuval, Glenn E. Palomaki, Yuval Yaron, et al.. (2006). Circulating angiogenic proteins in trisomy 13. American Journal of Obstetrics and Gynecology. 194(1). 239–245. 50 indexed citations
8.
Mitchell, M. L., Robert Z. Klein, James D. Sargent, et al.. (2003). Iodine sufficiency and measurements of thyroid function in maternal hypothyroidism. Clinical Endocrinology. 58(5). 612–616. 20 indexed citations
9.
Haddow, James E., Linda Bradley, Glenn E. Palomaki, & Richard A. Doherty. (1999). Issues in implementing prenatal screening for cystic fibrosis: results of a working conference. Journal of Medical Screening. 6(2). 60–66. 10 indexed citations
10.
Craig, Wendy Y., et al.. (1998). Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies. Clinical Chemistry. 44(11). 2301–2306. 166 indexed citations
11.
Doherty, Richard A., Linda Bradley, & James E. Haddow. (1997). Prenatal screening for cystic fibrosis: An updated perspective. American Journal of Obstetrics and Gynecology. 176(2). 268–270. 5 indexed citations
12.
Palomaki, Glenn E., et al.. (1997). Maternal serum screening for Down syndrome in the United States: A 1995 survey. American Journal of Obstetrics and Gynecology. 176(5). 1046–1051. 98 indexed citations
13.
Palomaki, Glenn E., James E. Haddow, George J. Knight, et al.. (1995). Risk‐based prenatal screening for trisomy 18 using alpha‐fetoprotein, unconjugated oestriol and human chorionic gonadotropin. Prenatal Diagnosis. 15(8). 713–723. 94 indexed citations
14.
Palomaki, Glenn E., Josephine Williams, James E. Haddow, & Marvin R. Natowicz. (1995). Tay‐sachs disease in persons of French‐Canadian heritage in northern New England. American Journal of Medical Genetics. 56(4). 409–412. 8 indexed citations
15.
Haddow, James E., Glenn E. Palomaki, George J. Knight, et al.. (1994). Reducing the Need for Amniocentesis in Women 35 Years of Age or Older with Serum Markers for Screening. New England Journal of Medicine. 330(16). 1114–1118. 162 indexed citations
16.
Craig, Wendy Y., et al.. (1990). Cigarette Smoking-Associated Changes in Blood Lipid and Lipoprotein Levels in the 8-to 19-Year-Old Age Group: A Meta-Analysis. PEDIATRICS. 85(2). 155–158. 41 indexed citations
17.
Wald, N J, Howard Cuckle, J. W. Densem, et al.. (1988). Maternal serum screening for Down's syndrome in early pregnancy.. BMJ. 297(6653). 883–887. 709 indexed citations breakdown →
18.
Haddow, James E., et al.. (1975). Ingestion of charcoal lighter fluid. The Journal of Pediatrics. 87(4). 633–636. 28 indexed citations
19.
Haddow, James E., et al.. (1975). In vitro enhancement of erythrocyte mercury uptake by spironolactone. Toxicology and Applied Pharmacology. 31(3). 527–533. 1 indexed citations
20.
Klein, Robert M. & James E. Haddow. (1968). Tract elements in health and disease.. PubMed. 201(202). 314–23. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Glenn E. Palomaki Breakdown of academic impact, for papers by George J. Knight Breakdown of academic impact, for papers by Allan Hackshaw Breakdown of academic impact, for papers by Samuel Shapiro Breakdown of academic impact, for papers by Charles J. Glueck Breakdown of academic impact, for papers by David W. Kaufman Breakdown of academic impact, for papers by Jan Lindemans Breakdown of academic impact, for papers by Claudia Langenberg Breakdown of academic impact, for papers by Norberto Perico Breakdown of academic impact, for papers by Ronald C.W.
Rankless by CCL
2026